EXOZYMES INC. Chief Scientific Officer Tyler Korman Acquires 5,332 Shares at $8.44

On April 1, 2026, Tyler Korman, Chief Scientific Officer of EXOZYMES INC. (ticker: EXOZ), acquired 5,332 shares of common stock at a price of $8.44 per share through a transaction coded as "A" (award, grant, or other acquisition). This acquisition increased Korman's total holdings to 730,623 shares. The Form 4 filing, signed on April 7, 2026, reports this transaction as required under Section 16 of the Securities Exchange Act of 1934. The transaction represents a significant purchase by a key executive officer, indicating continued investment in the company by its leadership. As Chief Scientific Officer, Korman's increased stake aligns his interests with shareholders and demonstrates confidence in the company's future prospects.